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Glucocorticoid (GC)-induced osteoporosis is the main cause of secondary
osteoporosis. Fractures, which are often asymptomatic, can occur in as many as
50% of patients receiving chronic GC therapy. GCs have direct and indirect effects
on bone cells (osteoblasts, osteocytes, and osteoclasts) with a suppression of bone
formation and an increased bone resorption. The management of patients exposed
to GCs should include the use of the minimal effective dose of GC, general health
measures, and adequate intakes of calcium and vitamin D. Bisphosphonates are
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